<
 
 
 
 
×
>
hide
You are viewing a Web site, archived on 01:00:22 Nov 10, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.

U. S. Food and Drug Administration Center for Drug Evaluation and Research

Oncologytoolscouple.GIF(7450 bytes)


App_Onc_Drugs.gif (2012 bytes)
Dis_Sum.gif (1491 bytes)
reg_tools.gif (1693 bytes)
Onc_Ref.gif (2226 bytes)
Pat_Liaison.gif (1806 bytes)
add_res.gif (1492 bytes)
Onc_T_Home.gif (1619 bytes)
Cder_Home.gif (1445 bytes)

FDA Review Divisions Responsible for Oncology Products

A number of FDA organizational units have responsibility for reviewing products used by cancer patients. The Center for Drug Evaluation and Research (CDER) evaluates and regulates drugs; the Center for Biologics Evaluation and Research (CBER) evaluates and regulates biologicals; and the Center for Devices and Radiological Health evaluates and regulates devices.

  Phone Fax
CDER Oncology Drug Products (most drugs) 301-594-2473 301-594-0499
CBER Oncology Branch (for biologicals) 301-827-5093 301-827-5394
CDER Urologic and Reproductive Drug Products (for prostate cancer hormones) 301-827-4260 301-827-4267
CDER Radiopharmaceuticals and Medical Imaging 301-827-7510 301-443-9281
CDER Gastrointestinal and Coagulation Drug Products 301-827-7310 301-443-9285
CDER Anesthetic, Critical Care and Addiction Drug Products (most pain medications) 301-827-7410 301-443-7068
CDER Endocrine and Metabolic Drug Products 301-827-6430 301 443-9282
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center for Food Safety and Applied Nutrition (CFSAN)

Procedure for Filing a Single Patient IND (Compassionate or Emergency Use)


FDA/Center for Drug Evaluation and Research
Last Updated: 
Originator: OTCOM/DLIS
HTML by  GYC;SH;CSA